-
Professor Qiang Liu: Progress in the Treatment of Early Triple-Negative Breast Cancer | Annual Review of the Northern Breast Cancer Salon
From January 5-6, 2024, the “Northern Breast Cancer Salon Annual Review and 2024 CSCO BC Guidelines Update Discussion” was held in Beijing. During the session on “Targeted Treatment-TNBC,” Professor Qiang Liu from Sun Yat-sen Memorial Hospital of Sun Yat-sen University presented a report on “Progress in the Treatment of Early Triple-Negative Breast Cancer (TNBC).” After…
-
Expert Perspective | Professor Hongmei Xu: Early Diagnosis and Treatment of Chronic Hepatitis B in Children
Editor’s Note:HBV infection remains a significant public health issue worldwide, with about 1.5 million new infections annually. As of 2019, there were 46.5 million children and adolescents globally suffering from…
-
Carrying China’s Voice to the World: Exclusive Interview with Professor Bijie Hu at ESCMID Global 2024
Editor’s Note: The 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), hosted by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), concluded successfully in…
-
Professor Ming Liu on the Advances in Bipolar Androgen Therapy for mCRPC
Bipolar Androgen Therapy (BAT) is an emerging treatment for metastatic castration-resistant prostate cancer (mCRPC) that significantly reduces prostate-specific antigen (PSA) levels in some patients, improves their quality of life, and restores sensitivity to castration treatments. This therapy has shown great potential in the treatment of mCRPC patients. On January 6, 2024, the “2024 Beijing Urological…
-
EBMT Spotlight | Professor Liang Huang: The Impact of Extranodal Involvement on CAR-T Cell Therapy in Large B-Cell Lymphoma
Large B-cell lymphoma (LBCL) is a common malignant hematologic disorder, representing 40% of all new non-Hodgkin lymphoma diagnoses. About 60% of patients respond to first-line standard immunotherapy, but the prognosis for high-risk patients is generally poor. Recently, chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated controllable safety and significant efficacy in the treatment of relapsed/refractory…
-
Professor Lei Fan: Internal Medicine Treatment and Research Progress of Ocular Lymphoma | First Academic Forum of the Ocular Lymphoma Collaboration Group
On March 30, 2024, the First Academic Forum of the Ocular Lymphoma Collaboration Group was successfully held in Beijing. It was hosted by Beijing Tongren Hospital affiliated with Capital Medical University, China Human Health Technology Promotion Association, Beijing Public Health Science Popularization Promotion Association, and Beijing Chen Jumei Charity Foundation. The event was organized by…
-
Professor Cuizhi Geng: Diverse Treatment Approaches Helping Breast Cancer Patients Toward Cure | 2024 CSCO Guidelines Conference
Breast cancer is one of the most common malignant tumors among women. Influenced by various factors, the incidence of breast cancer has been increasing year by year. With the addition of immunotherapy and targeted therapy, more breast cancer patients see hope for treatment. “Oncology Frontier” specially invited Professor Cuizhi Geng from The Fourth Hospital of…
-
Dr. Zhang Zedan and Dr. Deng Ruiyi from Professor Gong Kan’s Team Present Their Research on Renal and Upper Tract Urothelial Carcinoma at an International Conference
With the rapid advancements in the field of urologic oncology in China, an increasing number of Chinese studies are making their mark on the global stage. At the recent 39th European Association of Urology Annual Meeting (EAU24) held in Paris, France, Professor Gong Kan’s team from Peking University First Hospital presented several new research findings.…
Connecting Medical Expertise through Media